“OrbiMed Capital GP VI LLC”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  4/26/24  as  Registrant

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“OrbiMed Capital GP VI LLC” has been a Group Member with  one  Filer:

        

“OrbiMed Capital GP VI LLC” has/had a Group Member interest in  29  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
3/21/24		MA	Adicet Bio, Inc.	8	SC 13D/A	NY	Orbimed Advisors LLC
3/8/24		MD	NextCure, Inc.	3	SC 13D/A	NY	Orbimed Advisors LLC
2/14/24		CA	NeuroPace Inc.	4	SC 13G/A	NY	Orbimed Advisors LLC
2/14/24		CA	Crinetics Pharmaceuticals, Inc.	5	SC 13G/A	NY	Orbimed Advisors LLC
2/5/24		CA	CalciMedica, Inc.	4	SC 13D/A	NY	Orbimed Advisors LLC
1/25/24		CO	Edgewise Therapeutics, Inc.	3	SC 13D/A	NY	Orbimed Advisors LLC
12/29/23		WA	Alpine Immune Sciences, Inc.	10	SC 13D/A	NY	Orbimed Advisors LLC
12/15/23		MA	Disc Medicine, Inc.	4	SC 13D/A	NY	Orbimed Advisors LLC
12/6/23		CT	SpringWorks Therapeutics, Inc.	7	SC 13D/A	NY	Orbimed Advisors LLC
10/4/23		MA	Synlogic, Inc.	8	SC 13D/A	NY	Orbimed Advisors LLC
9/21/23		MA	Ikena Oncology, Inc.	4	SC 13D/A	NY	Orbimed Advisors LLC
7/24/23		CA	Turnstone Biologics Corp.	1	SC 13D	NY	Orbimed Advisors LLC
5/24/23		DE	Prelude Therapeutics Inc.	3	SC 13D/A	NY	Orbimed Advisors LLC
5/16/23			Verona Pharma plc	5	SC 13D/A	NY	Orbimed Advisors LLC
3/24/23		CA	89bio, Inc.	6	SC 13D/A	NY	Orbimed Advisors LLC
3/22/23		CA	CalciMedica Subsidiary, Inc.	1	SC 13D/A	NY	Orbimed Advisors LLC
12/27/22		CA	Oric Pharmaceuticals, Inc.	5	SC 13D/A	NY	Orbimed Advisors LLC
11/30/22		CA	ARS Pharmaceuticals, Inc.	2	SC 13D/A	NY	Orbimed Advisors LLC
11/29/22		MA	scPharmaceuticals Inc.	5	SC 13D/A	NY	Orbimed Advisors LLC
12/6/21		WA	Cti Biopharma Corp.	3	SC 13G/A	NY	Orbimed Advisors LLC
			More...  Please Sign In to list all 29 of them.

“OrbiMed Capital GP VI LLC” has been a Group Member with  13  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
3/21/24		NY	Carl L. Gordon	3	SC 13D/A	NY	Orbimed Advisors LLC	MA	Adicet Bio, Inc.
			Erez Chimovits	3
			Orbimed Advisors Israel II Ltd.	19
		NY	OrbiMed Capital GP V LLC	6
		NY	OrbiMed Genesis GP LLC	23
		•	OrbiMed Israel BioFund GP Limited Partnership	5
			OrbiMed Israel GP II, L.P.	19
			OrbiMed Israel GP Ltd.	6
1/25/24		NY	Orbimed Capital LLC	29	SC 13D/A	NY	Orbimed Advisors LLC	CO	Edgewise Therapeutics, Inc.
12/15/23		NY	OrbiMed Capital GP VIII LLC	3	SC 13D/A	NY	Orbimed Advisors LLC	MA	Disc Medicine, Inc.
6/29/23		•	Orbimed Israel Biofund Ltd. Partnership	1	SC 13D/A	NY	Orbimed Advisors LLC	MA	Adicet Bio, Inc.
9/9/19		NY	OrbiMed ROF II LLC	2	SC 13D/A	NY	Orbimed Advisors LLC	MA	Avedro Inc.
1/12/18		NY	Samuel D. Isaly	8	SC 13G	NY	Orbimed Advisors LLC	MA	KALA BIO, Inc.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“OrbiMed Capital GP VI LLC” has been a Signatory for/with  7  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
11/13/23		NY	Orbimed Advisors LLC	7	SC 13D/A	WA	Alpine Immune Sciences, Inc.
3/24/21		CA	NeuroPace Inc.	2	S-1	—
2/25/21		MA	KALA BIO, Inc.	1	10-K	—
2/11/21		MA	Disc Medicine, Inc.	11	8-K	—
9/4/20		DE	Prelude Therapeutics Inc.	2	S-1	—
11/16/17		NY	Isaly Samuel D	1	3	MA	scPharmaceuticals Inc.
11/16/17		NY	OrbiMed Capital GP VI LLC	1	3	MA	scPharmaceuticals Inc.

“OrbiMed Capital GP VI LLC” has/had a Signatory interest in  6  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
11/13/23		WA	Alpine Immune Sciences, Inc.	1	SC 13D/A	NY	Orbimed Advisors LLC
11/29/22		MA	scPharmaceuticals Inc.	2	SC 13D/A	NY	Orbimed Advisors LLC
9/16/22		CO	Edgewise Therapeutics, Inc.	1	SC 13D/A	NY	Orbimed Advisors LLC
12/14/21		MA	Adicet Bio, Inc.	2	SC 13D/A	NY	Orbimed Advisors LLC
1/13/21		DE	Prelude Therapeutics Inc.	1	SC 13D/A	NY	Orbimed Advisors LLC
10/19/20		MA	Disc Medicine, Inc.	1	425	MA	Disc Medicine, Inc.